Department of Nuclear Medicine/PET-CT, Kowsar Hospital, Shiraz, Iran.
Department of Radiology, Keck School of Medicine, University of Southern California (USC), Health Sciences Campus, 1500 San Pablo Street, Los Angeles, California 90033, USA.
PET Clin. 2020 Oct;15(4):547-558. doi: 10.1016/j.cpet.2020.06.008. Epub 2020 Aug 4.
During the past decades, the role of fludeoxyglucose (FDG)-PET and hybrid PET/computed tomography (CT) has been established clinically in the diagnostic workup of a multitude of infectious and inflammatory disorders. In recent years, the fusion of MR imaging to PET has also been increasingly explored, and this may be especially useful in musculoskeletal and gastrointestinal inflammatory diseases due to exceptional soft tissue contrast and reduced radiation dose. This article outlines the current potential for hybrid molecular imaging in the musculoskeletal system and the gastrointestinal tract with special focus on the potential for fused PET/CT/MR imaging.
在过去几十年中，氟脱氧葡萄糖（FDG）-PET 和混合 PET/计算机断层扫描（CT）在多种感染和炎症性疾病的诊断中已得到临床应用。近年来，MR 成像与 PET 的融合也在不断探索中，由于具有出色的软组织对比和较低的辐射剂量，这在肌肉骨骼和胃肠道炎症性疾病中可能特别有用。本文概述了混合分子成像在肌肉骨骼系统和胃肠道中的当前潜力，特别关注融合 PET/CT/MR 成像的潜力。
